Roche Announced Free Access to the Mysugr Pro App

INDIANAPOLIS : Roche, today announced free access to the mySugr Pro app to help the millions of Americans living with diabetes maintain their personalized daily diabetes routine during the COVID-19 crisis. This offer is especially beneficial as healthcare providers increasingly transition to remote patient visits.1,2

 

With the mySugr Pro app, users have access to valuable features to better manage their condition. They can create and share with their healthcare team detailed PDF reports of their aggregated diabetes data from Accu-Chek® blood glucose meters, blood sugar levels, carbohydrate intake, stress levels, insulin dosages, medication, and estimated HbA1c. This efficient overview of information helps healthcare providers recognize patterns and individualize guidance. For people with diabetes, this helps prompt questions about blood sugar highs and lows for discussion with healthcare providers, enabling a satisfying experience during remote visits.3

 

For people with diabetes, good glucose control is important in avoiding or reducing the severity of infection. The risk of getting very sick from COVID-19 is likely to be lower if diabetes is well managed.4

 

“It is more important than ever for people with diabetes to feel supported in their self-management and connected to their healthcare team,” said Matt Jewett, Senior Vice President and General Manager of Roche Diabetes Care, US. “Diabetes is well-suited to virtual care, and our goal is to facilitate highly productive interactions between healthcare providers and patients now and in the future.”

 

With more than 2 million registered users worldwide, the mySugr app eases the complexity of the daily diabetes routine with data, motivation and detailed reports.

 

According to the International Diabetes Federation5 nearly half a billion (463 million) adults worldwide are currently living with diabetes; by 2045 this number will rise to 700 million. Controlling glycemic levels is critical in preventing long-term microvascular and macrovascular complications.6 As with many chronic diseases, the achievement of optimal therapeutic outcomes relies on both treatment persistence and treatment adherence.

 

Founded in 2012 in Vienna, Austria, mySugr specializes in all-around care for people with diabetes. Its app and services combine diabetes coaching, therapy management, unlimited test-strips, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes.

 

To take better care during COVID-19 pandemic, tech-driven solutions are helping the people and connecting them with the doctors during any emergency. Best1tech, in this segment, offers an advanced healthcare solution that allows our clients to provide better services to their patients amid pandemic.

Contact us now.

Source: PR Newswire